Secure Drug Delivery Data Transmission via Selective Encryption
Solution Overview
Problem
Existing drug delivery systems face challenges in securely transmitting and managing delivery data while ensuring the privacy and integrity of protected health information, particularly when communicating over open networks.
Innovation Solution
An electronic unit associated with drug delivery devices, capable of generating, processing, and securely transmitting delivery data to specific subscribers using encryption keys and data allocation schemes, ensuring end-to-end encryption and secure data management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If data is transmitted over open networks for drug delivery monitoring, then data transmission capability is improved, but data security and privacy protection deteriorate
Solution Approach 1:
The patent segments data transmission by creating separate communication channels for different types of data (encrypted control data vs. unencrypted status data) and implementing layered security protocols. This allows simultaneous data transmission over open networks while maintaining security for sensitive information through selective encryption and data partitioning.
Solution Approach 2:
The patent introduces intermediary components including secure enclaves, trusted execution environments, and cryptographic protocol layers that mediate between the open network and sensitive data. These intermediaries act as security buffers, enabling data transmission while protecting privacy through cryptographic transformations and controlled access mechanisms.
2Reliability
If encryption is implemented for all data transmissions, then data security is improved, but processing time and computational resources increase
Solution Approach 1:
The patent applies local quality by implementing selective encryption where only specific sensitive data fields (patient identifiers, controlled substance information) are encrypted while less sensitive data (device status, operational parameters) remains unencrypted. This localized approach maintains security for critical information while minimizing processing overhead and transmission time.
Solution Approach 2:
The patent dynamically adjusts encryption parameters including key length, algorithm selection, and encryption scope based on data sensitivity classification and transmission context. This adaptive parameter changing optimizes the balance between security strength and processing efficiency, applying stronger encryption only when necessary.
Data Source
AI summary
The disclosure is concerned with privacy and integrity of personalized protected health information when transmitted to a cloud computing facility and subsequently distributed to a plurality of stakeholders. An electronic unit of a drug delivery device is configured to prepare payload data comprising data items according to an allocation scheme, and to encrypt, based on an encryption key, and transmit data including the payload data. The allocation scheme and the encryption key are defined for each of a plurality of data subscribers. Accordingly, personalized protected health information payload data is suitably protected with generator-to-subscriber or pass-through data security measures, and any intermediary node or data server in the communication network lacking a matching decryption key will not have access to unencrypted payload data.



